SLC25A family signaling refers to the functions of the Solute Carrier Family 25 (SLC25A) proteins, which are primarily involved in the transport of various molecules across the inner membranes of mitochondria. Members of this family, often referred to as mitochondrial carriers, are integral to mitochondrial function and play crucial roles in cellular metabolism and energy production. These transporters facilitate the exchange of substrates and products of metabolic pathways between the mitochondrial matrix and the cytosol, including ATP/ADP, calcium, phosphates, amino acids, and other metabolites. SLC25A proteins operate through a mechanism that typically involves the binding and translocation of a specific solute, which is often driven by concentration gradients.
Solute carrier family 25 (SLC25A) inhibitors comprise a specialized group of chemical compounds designed to target and modulate the activity of the SLC25A family of proteins, which are mitochondrial transporters integral to cellular energy metabolism. The SLC25A family encompasses numerous transporters, each with specificity for different types of molecules, including nucleotides (like ATP and ADP), amino acids, and other metabolic intermediates. These transporters play a critical role in maintaining the metabolic flux between the mitochondrial matrix and the cytosol, ensuring a balanced supply and exchange of key metabolites necessary for various cellular processes such as energy production, amino acid synthesis, and lipid metabolism. Inhibitors of SLC25A proteins are developed to selectively impede the transport activity of these carriers, thereby modulating the metabolic pathways in which they are involved.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Benzophenone | 119-61-9 | sc-254958 sc-254958A | 25 g 500 g | $20.00 $42.00 | ||
GPNA is believed to inhibit SLC25A transport function by competitively binding to its substrate-binding site, thus preventing the binding and transport of substrates. | ||||||
β-Chloro-L-alanine | 2731-73-9 | sc-291972 sc-291972A | 1 g 5 g | $138.00 $581.00 | 1 | |
The inhibition by β-Chloro-L-alanine could involve structural modifications in SLC25A that impede substrate recognition and disrupt the transport process. | ||||||
Glyoxylic acid solution | 298-12-4 | sc-255190 | 250 g | $40.00 | ||
Thionicotinamide's inhibitory mechanism might involve binding to specific residues in SLC25A, causing conformational changes that impair substrate transport. | ||||||
L-Methionine [R,S]-Sulfoximine | 15985-39-4 | sc-207806 | 1 g | $396.00 | ||
Methionine sulfoximine is thought to inhibit SLC25A indirectly by affecting downstream processes, leading to altered substrate availability for transport. | ||||||
Bongkrekic acid | 11076-19-0 | sc-205606 | 100 µg | $400.00 | 10 | |
Bongkrekic acid inhibits the adenine nucleotide translocase, a member of the SLC25A family, thereby indirectly affecting SLC25A. | ||||||
Elacridar | 143664-11-3 | sc-207613A sc-207613 sc-207613B sc-207613C sc-207613D | 5 mg 10 mg 50 mg 100 mg 1 g | $98.00 $113.00 $411.00 $525.00 $2606.00 | 19 | |
Elacridar inhibits various solute carriers and can potentially influence the function of SLC25A. | ||||||
Tenofovir | 147127-20-6 | sc-204335 sc-204335A | 10 mg 50 mg | $157.00 $646.00 | 11 | |
Tenofovir affects mitochondrial nucleotide transport, which may have an indirect effect on SLC25A. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glucose analog interferes with glycolysis and can influence mitochondrial transport proteins, including SLC25A. | ||||||
Mdivi-1 | 338967-87-6 | sc-215291 sc-215291B sc-215291A sc-215291C | 5 mg 10 mg 25 mg 50 mg | $67.00 $126.00 $251.00 $465.00 | 13 | |
Mdivi-1 inhibits mitochondrial division, potentially influencing mitochondrial transporters like SLC25A. | ||||||